Nexalin Technology (NXL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 Jun, 2026Executive summary
Annual Meeting scheduled for August 26, 2024, to be held virtually, with voting on key proposals including director elections, equity plan amendment, and auditor ratification.
Record date for voting is July 17, 2024; shareholders can vote online, by phone, or mail.
Proxy materials and annual report are available electronically to promote cost savings and environmental responsibility.
Voting matters and shareholder proposals
Shareholders will vote on electing five directors, amending the 2023 Equity Incentive Plan, and ratifying Marcum LLP as independent auditors for 2024.
Amendment to the equity plan seeks to increase reserved shares from 1,500,000 to 6,000,000.
Shareholders may submit proposals for the 2025 meeting by January 1, 2025.
Board of directors and corporate governance
Board consists of five members, with three deemed independent under NASDAQ standards.
Board committees include Audit, Compensation, and Nominating, each with defined charters and independent membership.
Board diversity matrix discloses gender and racial composition; one female and four male directors.
Board leadership structure separates Chairman and CEO roles for enhanced governance.
Latest events from Nexalin Technology
- Proprietary neurostimulation offers effective, scalable mental health solutions with global reach.NXL
Investor presentation8 Jun 2026 - Revenue up 79% to $302K, but $8.2M net loss and going concern risk persist.NXL
Q4 20258 Jun 2026 - Raises up to $7M for mental health device commercialization amid regulatory and financial risks.NXL
Registration filing8 Jun 2026 - Offering up to $7M in stock to fund neurostimulation device development amid regulatory and financial risks.NXL
Registration filing8 Jun 2026 - Offering up to $7M in stock to fund neurostimulation device development amid ongoing losses.NXL
Registration filing8 Jun 2026 - Revenue up 52% to $168K, net loss $7.6M, with ongoing going concern and regulatory risks.NXL
Q4 20248 Jun 2026 - Shelf registration enables up to $50M in offerings, including a $9.78M ATM program via Maxim Group LLC.NXL
Registration filing8 Jun 2026 - Registering 2.8M shares for resale, with proceeds from warrants to fund growth and development.NXL
Registration filing8 Jun 2026 - Q2 2025 revenue surged 163% year-over-year, but losses and cash burn remain significant.NXL
Q2 20258 Jun 2026